Affiliation:
1. University of Southern Santa Catarina (UNESC)
2. The University of Texas Health Science Center at Houston (UTHealth)
Abstract
Abstract
Background: Studies have demonstrated an
important impact of systemic inflammation in the central nervous
system, which could be related to psychiatric disorders’
pathophysiology. Ketamine can have anti-inflammatory proprieties,
but dose-dependently effects need to be studied.
Objective: To evaluate the effect of different
doses of ketamine on levels of neurotrophins and inflammatory
cytokines in the brains of rats.
Methods: Wistar rats were submitted to the
cecal ligation and puncture (CLP) model of sepsis. Thirty days
after the CLP procedure, the rats received an intraperitoneal
injection (i.p.) of ketamine (5, 15, or 25 mg/kg) or saline, once a
day for seven days. The rats were killed 30 minutes after the last
i.p. injection. The frontal cortex, hippocampus, and striatum were
dissected for analysis of IL-1𝛽, IL-6, IL-10, TNF-α, BDNF, NGF,
NT-3, and GDNF levels.
Results: CLP increased the levels of IL-1𝛽,
IL-6, IL-10, and TNF-α levels in the frontal cortex and/or
hippocampus of rats. Besides, BDNF levels were decreased by CLP in
all structures analyzed. NGF and GDNF were decreased only in the
hippocampus. Ketamine at 5 mg/kg reversed all alterations caused by
CLP and per se increased the levels of BDNF and NGF in the
frontal cortex and/or hippocampus. Ketamine at 15 mg/kg increased
BDNF and NGF levels. In turn, Ketamine at 25mg/kg potentiates the
inflammatory injury on the brain induced by CLP.
Conclusion:We suggest that ketamine could work
differently in a systemic inflammation environment, and caution
needs to be taken depending on the inflammatory history of the
patient.
Publisher
Research Square Platform LLC